BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33461772)

  • 21. Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma.
    Liu MJ; Liu ZF; Hou YY; Men YM; Zhang YX; Gao LY; Liu H
    Oncotarget; 2017 Apr; 8(16):27520-27528. PubMed ID: 28460476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
    Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
    [No Abstract]   [Full Text] [Related]  

  • 23. [Analysis of risk factors for central lymph node metastasis in papillary thyroid microcarcinoma].
    Wang ZH; Zhang YJ; Fu GM; Chen YB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):12-17. PubMed ID: 30704163
    [No Abstract]   [Full Text] [Related]  

  • 24. Ultrasound Elastic Parameters Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Guo JN; Song LH; Yu PY; Yu SY; Deng SH; Mao XH; Xiu C; Sun J
    J Surg Res; 2020 Sep; 253():69-78. PubMed ID: 32335393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
    Machens A; Dralle H
    Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sonographic features of primary tumor as independent predictive factors for lymph node metastasis in papillary thyroid carcinoma.
    Wu Q; Li Y; Wang Y; Hu B
    Clin Transl Oncol; 2015 Oct; 17(10):830-4. PubMed ID: 26041723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High frequency ultrasound features and pathological characteristics of medullary thyroid carcinoma.
    Wang H; Liu M; Yang J; Song Y
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2269-2271. PubMed ID: 28167464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
    Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
    J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of cervical lymph node metastasis in patients with papillary thyroid cancer using combined conventional ultrasound, strain elastography, and acoustic radiation force impulse (ARFI) elastography.
    Xu JM; Xu XH; Xu HX; Zhang YF; Guo LH; Liu LN; Liu C; Bo XW; Qu S; Xing M; Li XL
    Eur Radiol; 2016 Aug; 26(8):2611-22. PubMed ID: 26560715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma.
    Fan W; Xiao C; Wu F
    J Int Med Res; 2018 May; 46(5):1982-1989. PubMed ID: 29569965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
    Gui CY; Qiu SL; Peng ZH; Wang M
    J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nodal status of central lymph nodes as a negative prognostic factor for papillary thyroid carcinoma.
    Lee YS; Lim YS; Lee JC; Wang SG; Kim IJ; Son SM; Shin DH; Lee BJ
    J Surg Oncol; 2013 Jun; 107(7):777-82. PubMed ID: 23640873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
    Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
    J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis.
    Qu H; Sun GR; Liu Y; He QS
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):124-32. PubMed ID: 25130203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Distribution of cervical lymph node metastasis in well-differentiated thyroid carcinoma].
    Bian X; Xu ZG; Zhang B; Liu WS; Mao CY; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Aug; 41(8):599-602. PubMed ID: 17039802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of lateral neck lymph node metastasis according to preoperative calcitonin level and tumor size for medullary thyroid carcinoma.
    Bae SY; Jung SP; Choe JH; Kim JS; Kim JH
    Kaohsiung J Med Sci; 2019 Dec; 35(12):772-777. PubMed ID: 31483088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.
    Li M; Zhu XY; Lv J; Lu K; Shen MP; Xu ZL; Wu ZS
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3801-3807. PubMed ID: 28975988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion.
    Xu SY; Yao JJ; Zhou W; Chen L; Zhan WW
    Head Neck; 2019 Nov; 41(11):3984-3991. PubMed ID: 31463972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RET Proto-oncogene Gene Mutation Is Related to Cervical Lymph Node Metastasis in Medullary Thyroid Carcinoma.
    Wang S; Wang B; Xie C; Ye D
    Endocr Pathol; 2019 Dec; 30(4):297-304. PubMed ID: 31494787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound features of medullary thyroid carcinoma correlate with cancer aggressiveness: a retrospective multicenter study.
    Trimboli P; Giovanella L; Valabrega S; Andrioli M; Baldelli R; Cremonini N; Rossi F; Guidobaldi L; Barnabei A; Rota F; Paoloni A; Rizza L; Fattorini G; Latini M; Ventura C; Falasca P; Orlandi F; Crescenzi A; D'Ambrosio F; Cantisani V; Romanelli F; Negro R; Saggiorato E; Appetecchia M
    J Exp Clin Cancer Res; 2014 Oct; 33(1):87. PubMed ID: 25344474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.